The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: An analysis of the randomized Hokusai Venous Thromboembolism Cancer trial

Authors

• Nick van Es, University of Amsterdam
• Luuk J J Scheres, Leiden University Medical Center
• Kristen M Sanfilippo, Washington University School of Medicine in St. Louis
• Harry Büller, University of Amsterdam
• Marc Carrier, University of Ottawa
• Marcello Di Nisio, "G. D'Annunzio" University
• Michael Grosso, Daiichi Sankyo
• Renato D Lopes, Duke University
• William F McIntyre, Population Health Research Institute
• Bjorn Redfors, Weill Cornell Medical College
• Annelise Segers, International Trial Expertise Advisory and Services
• Peter Verhamme, University Hospitals Leuven
• Jeffrey I Weitz, McMaster University
• Patrick M Bossuyt, University of Amsterdam
• Deborah M Siegal, St. Louis Veterans Administration Medical Center

Journal

Journal of Thrombosis and Haemostasis

Publication Date

3-1-2026

Volume

24

Issue

3

First Page

1032

Last Page

1041

Document Type

Open Access Publication

DOI

10.1016/j.jtha.2025.11.024

Rights and Permissions

van Es N, Scheres LJJ, Sanfilippo KM, Büller H, Carrier M, Di Nisio M, Grosso M, Lopes RD, McIntyre WF, Redfors B, Segers A, Verhamme P, Weitz JI, Bossuyt PM, Siegal DM. The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial. J Thromb Haemost. 2026 Mar;24(3):1032-1041. doi: 10.1016/j.jtha.2025.11.024. © 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Recommended Citation

van Es, Nick; Scheres, Luuk J J; Sanfilippo, Kristen M; Büller, Harry; Carrier, Marc; Di Nisio, Marcello; Grosso, Michael; Lopes, Renato D; McIntyre, William F; Redfors, Bjorn; Segers, Annelise; Verhamme, Peter; Weitz, Jeffrey I; Bossuyt, Patrick M; and Siegal, Deborah M, "The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: An analysis of the randomized Hokusai Venous Thromboembolism Cancer trial." Journal of Thrombosis and Haemostasis. 24, 3. 1032 - 1041. (2026).
https://digitalcommons.wustl.edu/oa_4/6559

Department

ICTS (Institute of Clinical and Translational Sciences)